Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study
Zeitschrift für Gastroenterologie | November 22, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available
10.1055/s-0041-1734235